BRS (Brontuss dextromethorphan hydrobromide 20 mg / guaifenesin 400 mg)
Generic Name: dextromethorphan/guaifenesin
Pill imprint BRS has been identified as Brontuss dextromethorphan hydrobromide 20 mg / guaifenesin 400 mg.
Brontuss is used in the treatment of expectoration; cough and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Brontuss dextromethorphan hydrobromide 20 mg / guaifenesin 400 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- dextromethorphan hydrobromide 20 mg / guaifenesin 400 mg
- Rx and/or OTC
- Drug Class:
- Upper respiratory combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Portal Pharmaceuticals
More about Brontuss (dextromethorphan / guaifenesin)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- 0 Reviews – Add your own review/rating
- Drug class: upper respiratory combinations
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.